Stephen Oesterle
Venture Partner at Cathay Capital
Stephen Oesterle
Venture Partner at Cathay Capital
Minneapolis, Minnesota
Overview
Work Experience
Health Care Consultant
2015 - Current
Board Director
2017
Public Company: (NYSE: BAX) Quality & Compliance Committee, Chair Nominating, Governance and Public Policy Committee Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For 90 years, Baxter has been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com
Independent Non Executive Board Director
2020
Public company, Hong Kong Exchange (9996.HK), Structural Heart and Neuro Interventions Nominating Committee Compensation Committee
Board Director
2021
Public Company (NYSE: FNA) focusing on orthopedic solutions in the foot and ankle Quality,Technology and Compliance Committee , Chair Nominating /Governance Committee
Independent Board Director
2022
Quality Committee, Chair Renumeration Committee CeramTec is a privately held manufacturer and supplier of technical ceramics since 1903 and is active at production sites in Europe, USA and Asia with more than 3,470 employees worldwide. Ceramtec develops and produces customer-specific medium and large components made of various ceramic materials for medical and industrial applications.
Independent Board Director
2020
Privately held global leader in the supply of auto-injectors for biologics.
Board Director
2017
Compensation Committee Late stage venture backed biotech company focused targeted precision delivery of gene therapies to the central nervous system and spinal cord
Alcyone Therapeutics is Pioneering Next-Generation Precision CNS Genetic Therapies to unlock new possibilities
Raised $23,000,000.00 from RTW Investments.
Corporate Advisor
2015
Industrial Advisor
2015
EQT is a purpose-driven global investment organization, focused on active ownership strategies. With a Nordic heritage and a global mindset, EQT has a track record of almost three decades of delivering consistent and attractive returns across multiple geographies, sectors and strategies. Uniquely, EQT is the only large private markets firm in the world with investment strategies covering all phases of a business’ development, from start-up to maturity. EQT today has more than EUR 70 billion in assets under management across 27 active funds within two business segments
Venture Partner
2020